Dose Optimization of MDMA-Assisted Therapy for PTSD

Recruiting now · Phase 2

Conditions studied: Posttraumatic Stress Disorder

In brief

This open label, within-subjects dose optimization trial will investigate the optimal number of MDMA-Assisted Therapy treatment cycles (i.e., one MDMA session and three integration sessions) in a sample of U.S. veterans with PTSD. Participants will complete from one to five cycles of MDMA-AT.

Key facts

Study ID
NCT06418178
Run by
Bronx VA Medical Center
People needed
60
Starts
2025-06-03
Expected to finish
2029-10-01
Last updated by the study team
2025-06-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.